Diabordo, Jeralyn D.

HRN: 29-24-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2026
CEFUROXIME 750MG (VIAL)
06/26/2026
07/03/2026
IV
750mg
Q8
UTI
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines